Is the US prepared to deal with another pandemic or widespread health crisis?

[1][2]No, the US is not fully prepared for another pandemic or major widespread health crisis, though it has improved in some technical areas since COVID-19. Assessments from government watchdogs, bipartisan commissions, public health organizations, WHO evaluations, and experts consistently describe partial progress overshadowed by persistent gaps, incomplete lesson implementation, funding/workforce instability, eroded trust, and recent setbacks that have left the country more vulnerable in key respects.[2]

Post-COVID Improvements

The Biden administration and prior efforts built on COVID lessons with tangible advances:

These built resilience for detection, stockpiling, and rapid tech response compared to early 2020. The US also contributed heavily to global efforts (e.g., vaccine sharing, Pandemic Fund).

Persistent and Worsening Gaps

Significant vulnerabilities remain, and many experts argue the US is less prepared in critical soft and systemic areas than needed—or even than pre- or mid-COVID in some ways:

Experts (e.g., in NEJM, Scientific American, Guardian, Contagion Live) note that while tech/hardware advanced, political will, sustained investment, trust, and international cooperation have faltered. The Global Preparedness Monitoring Board and others describe global (including US-influenced) progress as fragile/uneven, with risks outpacing reforms. Recent outbreaks (severe flu, measles resurgence, H5N1, Ebola/hantavirus concerns) expose strains.[7]

Bottom Line and Outlook

The US could manage a moderate or known-threat crisis better than the chaotic early COVID response due to stockpiles, surveillance upgrades, and experience. However, a novel, highly transmissible/severe pandemic (respiratory virus, engineered agent, or major zoonotic spillover) would still likely overwhelm hospitals, strain supply chains, face communication/trust barriers, and suffer from coordination/funding gaps—potentially with high excess mortality, especially among vulnerable groups. Preparedness is uneven across states and fragile nationally.

Sustained bipartisan investment in core public health infrastructure, workforce, data systems, countermeasures R&D/stockpiling, trust-building/communication, equitable access, and international partnerships (plus full implementation of existing recommendations like those from GAO, Biodefense Commission, and JEE) would markedly improve readiness. Without that, the pattern of “forget after the crisis” risks repeating, leaving the country underprepared despite its resources and scientific capacity. Threats like emerging pathogens, AMR, and climate-driven events make this urgent rather than hypothetical.